Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly.
about
Development of a unidimensional composite measure of neuropsychological functioning in older cardiac surgery patients with good measurement precisionHealth-related quality of life and economic impact of urinary incontinence due to detrusor overactivity associated with a neurologic condition: a systematic reviewA comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes.Botulinum toxin in neurogenic detrusor overactivity.Transdermal oxybutynin: a review.Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin.In vitro safety pharmacology profiling: what else beyond hERG?Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients.Anticholinergics for overactive bladder therapy: central nervous system effects.An overview on mixed action drugs for the treatment of overactive bladder and detrusor overactivity.Safe prescribing of physical health medication in patients with dementia.Safety and Effectiveness of Mirabegron in Patients with Overactive Bladder in a Real-World Clinical Setting: A Japanese Post-Marketing Study.Antimuscarinic Medication Use in Elderly Patients with Overactive Bladder.Safety issues associated with using medication to treat overactive bladder.Characterization of bladder selectivity of antimuscarinic agents on the basis of in vivo drug-receptor binding.Synthesis of a quaternary bis derivative of imipramine as a novel compound with potential anti-enuretic effect.Morphological changes in the salivary acini after in vivo cholinergic stimulation.Inhibitory effects of different ATP-sensitive potassium channel openers on electrically generated and carbachol-induced contractions of porcine and human detrusor muscle.Safety and Effectiveness of Mirabegron in Patients with Overactive Bladder Aged ≥75 Years: Analysis of a Japanese Post-Marketing Study.Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder.Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder.Anticholinergic prescription: are healthcare professionals the real burden?Evaluation of drug efflux transporter liabilities of darifenacin in cell culture models of the blood-brain and blood-ocular barriers.Differential Prescribing of Antimuscarinic Agents in Older Adults with Cognitive Impairment.Evaluation of cognitive function in healthy older subjects treated with fesoterodine.Association of urgency symptoms with self-rated health, mood and functioning in an older population."Wanting to be a good father": experiences of adolescent fathers of Mexican descent in a teen fathers program.
P2860
Q34058087-D5267D48-42EE-4DA3-AADF-1351C84693E7Q34569906-594D8637-AFD7-4F72-BA93-B373C97175EDQ35183619-67515B01-AFF2-48FD-8601-F51CA627570AQ36283014-C84A6A86-9C94-4374-9300-D3012CF26BDFQ36313192-222EF7CD-6892-4D1F-91B9-05D5C1A269D9Q36835834-C63F083F-BF5C-4E89-88B3-2CB5782E04D9Q37242704-9E787072-CB79-4484-A434-EF11E240CF9EQ37855844-49FA1CEE-0A79-455C-9406-079900339935Q37879017-AF970F3E-F087-4981-824E-F3C840A50DDDQ37954372-6CD0E798-B344-4104-99DE-75CAB92F39DAQ38024986-E5F47AB2-0437-4B6F-BEAE-38493B0B8A9DQ38237044-AADA81FE-8ACC-4027-B494-8F1B50906143Q39176604-AC70CAEF-1C56-4AD1-B50D-74B8FF010AD0Q39342723-DEFAE351-E3B2-403F-B602-1E8A3E981582Q40058585-0E26643D-F63D-41D0-8222-5D3FDA2981BDQ42428489-7898D01C-82D6-46C5-AA19-EBF0B1BEBF0EQ43286998-FCAAB355-8EEC-4914-91FE-1DFC1EE99F70Q46255910-C0CB4449-5F99-4F20-8102-5A62FA8D2763Q46770813-2FC9278E-6F7F-41DB-8AAD-1AC6A7A11BC2Q47993403-84FADD38-4D81-40A3-95D5-BB67187B2528Q48054495-E5A318A4-6782-4C7D-AE02-5BF29E0CBA49Q48160047-BC8A85CC-849E-45E4-ACE5-EA01D9ADF168Q48350162-E7A1C93C-39DB-4217-B1FE-B1110D01BF40Q48957750-676EA239-722F-4062-A66E-79B387E75598Q50533611-7789EC24-5148-4FDF-9EC5-808C24B502AEQ50753347-668F3D60-FA5C-4FFF-AF87-FDFD7EF6A087Q50876870-471C135A-FC6F-4457-B5FC-DD35A2306453Q50938578-20639423-BFB8-4849-9FD3-2CD75751ADFA
P2860
Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Antimuscarinic agents: implica ...... active bladder in the elderly.
@ast
Antimuscarinic agents: implica ...... active bladder in the elderly.
@en
type
label
Antimuscarinic agents: implica ...... active bladder in the elderly.
@ast
Antimuscarinic agents: implica ...... active bladder in the elderly.
@en
prefLabel
Antimuscarinic agents: implica ...... active bladder in the elderly.
@ast
Antimuscarinic agents: implica ...... active bladder in the elderly.
@en
P1476
Antimuscarinic agents: implica ...... active bladder in the elderly.
@en
P2093
Gary G Kay
Lisa J Granville
P304
127-38; quiz 139-40
P356
10.1016/J.CLINTHERA.2005.01.006
P577
2005-01-01T00:00:00Z